173 related articles for article (PubMed ID: 25134537)
1. Oncomodulin/truncated protamine-mediated Nogo-66 receptor small interference RNA delivery promotes axon regeneration in retinal ganglion cells.
Cui Z; Kang J; Hu D; Zhou J; Wang Y
Mol Cells; 2014 Aug; 37(8):613-9. PubMed ID: 25134537
[TBL] [Abstract][Full Text] [Related]
2. Schwann cell-derived factor-induced modulation of the NgR/p75NTR/EGFR axis disinhibits axon growth through CNS myelin in vivo and in vitro.
Ahmed Z; Suggate EL; Brown ER; Dent RG; Armstrong SJ; Barrett LB; Berry M; Logan A
Brain; 2006 Jun; 129(Pt 6):1517-33. PubMed ID: 16613894
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant adeno-associated virus conducted NgR(DN) enhances axonal regeneration of optic nerve after trauma: experiment with rats].
Wang F; Wang JQ; Su Y; Shan YC; Zhao SG; Teng Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2856-60. PubMed ID: 18167294
[TBL] [Abstract][Full Text] [Related]
4. Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.
Douglas MR; Morrison KC; Jacques SJ; Leadbeater WE; Gonzalez AM; Berry M; Logan A; Ahmed Z
Brain; 2009 Nov; 132(Pt 11):3102-21. PubMed ID: 19783665
[TBL] [Abstract][Full Text] [Related]
5. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state.
Fischer D; He Z; Benowitz LI
J Neurosci; 2004 Feb; 24(7):1646-51. PubMed ID: 14973241
[TBL] [Abstract][Full Text] [Related]
6. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.
Fournier AE; Gould GC; Liu BP; Strittmatter SM
J Neurosci; 2002 Oct; 22(20):8876-83. PubMed ID: 12388594
[TBL] [Abstract][Full Text] [Related]
7. Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.
Peng X; Zhou Z; Hu J; Fink DJ; Mata M
J Biol Chem; 2010 Jan; 285(4):2783-95. PubMed ID: 19901030
[TBL] [Abstract][Full Text] [Related]
8. Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm.
Pourabdolhossein F; Mozafari S; Morvan-Dubois G; Mirnajafi-Zadeh J; Lopez-Juarez A; Pierre-Simons J; Demeneix BA; Javan M
PLoS One; 2014; 9(9):e106378. PubMed ID: 25184636
[TBL] [Abstract][Full Text] [Related]
9. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
10. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist.
Hu F; Liu BP; Budel S; Liao J; Chin J; Fournier A; Strittmatter SM
J Neurosci; 2005 Jun; 25(22):5298-304. PubMed ID: 15930377
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of functionalized multi-walled carbon nanotubes on spinal cord injury in rats.
Ding S; Bao Y; Lin Y; Pan Y; Fan Y; Wan J; Jiang J
Int J Clin Exp Pathol; 2015; 8(12):15769-77. PubMed ID: 26884846
[TBL] [Abstract][Full Text] [Related]
12. Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A.
Ahmed Z; Dent RG; Suggate EL; Barrett LB; Seabright RJ; Berry M; Logan A
Mol Cell Neurosci; 2005 Mar; 28(3):509-23. PubMed ID: 15737741
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
14. Soluble Nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma.
Fu QL; Liao XX; Li X; Chen D; Shi J; Wen W; Lee DH; So KF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8374-80. PubMed ID: 21948553
[TBL] [Abstract][Full Text] [Related]
15. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of retinal ganglion cell axonal outgrowth through the Amino-Nogo-A signaling pathway.
Huo Y; Yin XL; Ji SX; Zou H; Lang M; Zheng Z; Cai XF; Liu W; Chen CL; Zhou YG; Yuan RD; Ye J
Neurochem Res; 2013 Jul; 38(7):1365-74. PubMed ID: 23579387
[TBL] [Abstract][Full Text] [Related]
17. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
Nyatia E; Lang DM
Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
[TBL] [Abstract][Full Text] [Related]
18. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
[TBL] [Abstract][Full Text] [Related]
19. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
20. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
